Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

REGISTER for free or LOG IN to view this content

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Coronary

TCT 2021

CAD Pharma

Up Next

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

More slides +

Presentation TCT 2021

TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study

Presenter: Nishtha Sodhi

November 05, 2021

Presentation TCT 2021

TCT 102: Assessing the Risk of Neo-Left Ventricular Outflow Tract Obstruction in Transcatheter Mitral Valve Replacement: Are We Treating All the Patients That Can be Treated?

Presenter: Keshav Kohli

November 05, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.